The newly raised investment will support Mave Health in launching Arc, a non-invasive brain stimulation wearable that treats depression.

Dhampur Sugar Mills, incorporated in the year 1933, is a Small Cap company (having a market cap of Rs 1516.29 Crore) operating in Sugar sec...

This newly leased workspace is located at Krimson Square, Hosur Road, HSR Layout, Bangalore and is home to multiple renowned companies. Thi...

The Supertech twin towers in Noida were demolished on Sunday, a year after the Supreme Court's direction to raze the illegally built struct...

The company said it helps people suffering from lifestyle disorders find discrete and convenient solutions at home and would utilize the fu...

Debt markets platform CredAvenue has brought on board Abhishek Mehrotra as chief human resource officer. Mehrotra joins the firm from Byted...

They feel reduced GST on leasing would have helped in the recovery of the office space segment, which has been the most impacted sector due...

The fund will be used to expand the brand’s geographical presence and integrate it deeper into the diagnostics ecosystem.

The analyst suggested a stoploss at Rs 195.

The analyst suggested a stoploss at Rs 184.

“Reliability on 5G technology and a vision of getting optimised speed to drive IoT is the future which India is looking to,” said Pamela Ku...

Buy Dhampur Sugar Mills Ltd. at a price target of Rs 155.0 and a stoploss at Rs 13350 from entry point.

The combined revenue of the acquired products is estimated at more than $70 million and forms a mix of high-potency steroidal, antiviral, e...

AppVirality, a San Francisco and Hyderabad-based startup, has raised about Rs 3.3 crore from Click Labs, Google’s Rajan Anandan, Bikky Khos...

Dani and Gulati were part of the executive management committee, the apex leadership team responsible for running day-to-day operations.

They will leverage their experience of spearheading the Indian drug maker’s operations as it encountered a series of regulatory setbacks in...

The changes come within months of Sun Pharmaceutical Industries agreeing to acquire Ranbaxy from Japan’s Daiichi Sankyo under a $4 billion ...